GlaxoSmithKline: Reorganizing Drug Discovery (A). Front Cover. Robert S. Huckman. Harvard Bibliographic information. QR code for GlaxoSmithKline. Free Essay: This case describes the reorganization of drug discovery at GlaxoSmithKline (GSK) following the formation of GSK from the merger. View Homework Help – GSk from MBA at Pace University. GlaxoSmithKline: Reorganizing Drug Discovery MBA Managing Innovation Professor John C.

Author: Arashim Moogugami
Country: Kazakhstan
Language: English (Spanish)
Genre: Politics
Published (Last): 19 July 2014
Pages: 316
PDF File Size: 8.49 Mb
ePub File Size: 1.32 Mb
ISBN: 587-9-45877-341-3
Downloads: 35998
Price: Free* [*Free Regsitration Required]
Uploader: JoJoshicage

Sometimes the two coincide, but often, they do not, and usually you have no idea until the drug is tested out in humans.

Then, the painstaking work of running a million compounds through high-throughput screening is also labor-intensive and resource-intensive. What is your topic? Over 30 successfully finished orders.

This site uses cookies. To find out more, including how to control cookies, see here: Smaller firms have specialist competencies in new glaxosmitbkline including genetics, molecular biology, chemistry and computer sciences.

GlaxoSmithKline: Reorganizing Drug Discovery (A) | star on earth

You are commenting using your Twitter account. Reorganizing Drug Discovery A. I wrote it in a blitz of inspiration after my Organizational Strategy class. At the hand-off to the clinic or to idscovery who will develop the drugs further, there needs to be a point of closure so that the discovery people can move forward to new projects with renewed reorgwnizing without having their energy tied to something that is no longer completely in their hands.


Yamada understood that large pharmaceutical firms were very good at the front-end of drug discovery and at the later stages of drug development. The point of a drug discovery team is to push forward relentlessly — not just work hard, as a former scientist friend at work told me, but to work smart.

There is a strong chance in glaxxosmithkline phase that IND will fail.

Case Report: Glaxosmithkline Reorganizing Drug Discovery (a) Essay Example | Graduateway

This reorganization placed nearly 2, research scientists into six centers of excellence in drug discovery CEDD. Finance General Management Marketing. Unlocking the Potential of Process Innovation. Reputation is very important in experience good markets.

Or the side effects are quite unbearable! Due to the large number of employees, swapping to a new technology resulted in extra spending. Each CEDD focused on a small set of therapeutic areas and possessed decision rights over the progression of pharmaceutical compounds through the early stages of development.

This results in developing 80 drugs in 18 months. By clicking “SEND”, you agree to our terms of service and privacy policy. Screening technology and organizational processes can be used across multiple areas.


GlaxoSmithKline: Reorganizing Drug Discovery (A)

This productivity decline lessens as doctors learn from experience. How About Make It Original? Yamada innovation was made in house and not bought in as Bayer did. Page count 1 page words.

We’ll occasionally send you account related and promo emails. Bachelor’s or higher degree.

Case Report: Glaxosmithkline Reorganizing Drug Discovery (a) Essay

Huckman and Eli Strick. About the Author Robert S. Maria Ibanez, Jonathan R. Specialist teams can be formed to carry out specific complex tasks which are common across various areas of the process. This is in response to the Harvard Business Case with the same title as this blog post. Yet employees often have discretion to deviate from their prescribed sequence.